Funding news
Beeline Medicines logo

Beeline Medicines Raises $126

Recently funded · $126.3M Series aHospitals and Health CareUSView source

Get the full Beeline Medicines company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Beeline Medicines, a clinical-stage biotechnology company focused on precision therapies for autoimmune and inflammatory diseases, has closed a substantial Series A funding round. The company secured $126.3M to advance its portfolio of therapeutic candidates.

This significant capital infusion, backed by investors including Bain Capital, CPPIB, and BMS, will fuel Beeline's mission to deliver treatments that go straight to the drivers of immune dysfunction. The biotech firm aims to redefine treatment paradigms and transform the lives of people living with these conditions.

From the source

Simply · Jun 30, 2026

🐝 The bee-hive is buzzing, and the message is clear: top-tier talent drives unstoppable momentum. Just 2.5 months after emerging from stealth with $300M, Beeline Medicines has secured a massive $126.3M Series A extension from heavyweights like Bain Capital, CPPIB, and BMS.

What makes this a masterclass in biotech growth? Leadership and execution. A Proven Playbook: Led by veterans of SpringWorks Therapeutics (who shepherded a $3.9B buyout in 2025), Beeline’s team has "run the full race" before. They have the expertise to take their five autoimmune assets all the way to regulatory approval without partnering them out. Clinical Momentum: With Phase 2 data for their l

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Tomato Jos logo

Tomato Jos

Nigeria

$4.0M
2
Sycamore.NG logo

Sycamore.NG

Nigeria

$6.0M
3
BFREE logo

BFREE

United States

$5.0M
4
Ognomy Sleep logo

Ognomy Sleep

United States

$20.0M
5
Qashier logo

Qashier

Singapore

$6.1M